Logo image of BTCM

BIT MINING LTD - SPON ADR (BTCM) Stock Fundamental Analysis

NYSE:BTCM - New York Stock Exchange, Inc. - US0554742090 - ADR - Currency: USD

1.84  -0.17 (-8.46%)

After market: 1.8 -0.04 (-2.17%)

Fundamental Rating

3

BTCM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. While BTCM seems to be doing ok healthwise, there are quite some concerns on its profitability. BTCM has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BTCM had positive earnings in the past year.
In the past year BTCM has reported a negative cash flow from operations.
BTCM had negative earnings in 4 of the past 5 years.
In the past 5 years BTCM always reported negative operating cash flow.
BTCM Yearly Net Income VS EBIT VS OCF VS FCFBTCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

BTCM's Return On Assets of 13.98% is amongst the best of the industry. BTCM outperforms 90.11% of its industry peers.
BTCM has a Return On Equity of 21.22%. This is amongst the best in the industry. BTCM outperforms 86.93% of its industry peers.
Industry RankSector Rank
ROA 13.98%
ROE 21.22%
ROIC N/A
ROA(3y)-71.39%
ROA(5y)-56.06%
ROE(3y)-133.77%
ROE(5y)-97.68%
ROIC(3y)N/A
ROIC(5y)N/A
BTCM Yearly ROA, ROE, ROICBTCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Profit Margin, with a value of 36.67%, BTCM belongs to the top of the industry, outperforming 96.47% of the companies in the same industry.
The Gross Margin of BTCM (9.07%) is worse than 86.57% of its industry peers.
BTCM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 36.67%
GM 9.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y179.81%
GM growth 5YN/A
BTCM Yearly Profit, Operating, Gross MarginsBTCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

5

2. Health

2.1 Basic Checks

BTCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BTCM has been increased compared to 1 year ago.
BTCM has more shares outstanding than it did 5 years ago.
There is no outstanding debt for BTCM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BTCM Yearly Shares OutstandingBTCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BTCM Yearly Total Debt VS Total AssetsBTCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -8.26, we must say that BTCM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BTCM (-8.26) is worse than 85.87% of its industry peers.
There is no outstanding debt for BTCM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.26
ROIC/WACCN/A
WACC10.95%
BTCM Yearly LT Debt VS Equity VS FCFBTCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 1.70 indicates that BTCM should not have too much problems paying its short term obligations.
BTCM's Current ratio of 1.70 is in line compared to the rest of the industry. BTCM outperforms 53.71% of its industry peers.
BTCM has a Quick Ratio of 1.70. This is a normal value and indicates that BTCM is financially healthy and should not expect problems in meeting its short term obligations.
BTCM has a Quick ratio (1.70) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
BTCM Yearly Current Assets VS Current LiabilitesBTCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for BTCM have decreased strongly by -26.52% in the last year.
BTCM shows a strong growth in Revenue. In the last year, the Revenue has grown by 122.99%.
EPS 1Y (TTM)-26.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)122.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.51%

3.2 Future

The Earnings Per Share is expected to decrease by -72.80% on average over the next years. This is quite bad
Based on estimates for the next years, BTCM will show a very negative growth in Revenue. The Revenue will decrease by -37.14% on average per year.
EPS Next Y-137.09%
EPS Next 2Y-90.53%
EPS Next 3Y-72.8%
EPS Next 5YN/A
Revenue Next Year-83.22%
Revenue Next 2Y-55.04%
Revenue Next 3Y-37.14%
Revenue Next 5YN/A

3.3 Evolution

BTCM Yearly Revenue VS EstimatesBTCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
BTCM Yearly EPS VS EstimatesBTCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 2024 0 5 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.17 indicates a rather cheap valuation of BTCM.
Compared to the rest of the industry, the Price/Earnings ratio of BTCM indicates a rather cheap valuation: BTCM is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.25, BTCM is valued rather cheaply.
With a Price/Forward Earnings ratio of 18.50, BTCM is valued on the expensive side.
Based on the Price/Forward Earnings ratio, BTCM is valued a bit cheaper than the industry average as 76.68% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, BTCM is valued at the same level.
Industry RankSector Rank
PE 0.17
Fwd PE 18.5
BTCM Price Earnings VS Forward Price EarningsBTCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

94.70% of the companies in the same industry are more expensive than BTCM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.06
BTCM Per share dataBTCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

BTCM's earnings are expected to decrease with -72.80% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-90.53%
EPS Next 3Y-72.8%

More info and screens

0

5. Dividend

5.1 Amount

BTCM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIT MINING LTD - SPON ADR

NYSE:BTCM (5/30/2025, 8:04:01 PM)

After market: 1.8 -0.04 (-2.17%)

1.84

-0.17 (-8.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-28 2025-02-28/amc
Earnings (Next)N/A N/A
Inst Owners3.38%
Inst Owner Change-0.93%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.36M
Analysts43.33
Price TargetN/A
Short Float %70.95%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-59.1%
Min Revenue beat(2)-70.77%
Max Revenue beat(2)-47.44%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-46.68%
Valuation
Industry RankSector Rank
PE 0.17
Fwd PE 18.5
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 0.64
EV/EBITDA 7.06
EPS(TTM)11.1
EY603.26%
EPS(NY)0.1
Fwd EY5.4%
FCF(TTM)-2.13
FCFYN/A
OCF(TTM)-2.05
OCFYN/A
SpS2.06
BVpS3.57
TBVpS2.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.98%
ROE 21.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 36.67%
GM 9.07%
FCFM N/A
ROA(3y)-71.39%
ROA(5y)-56.06%
ROE(3y)-133.77%
ROE(5y)-97.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y179.81%
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 10.18%
Cap/Sales 3.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z -8.26
F-Score5
WACC10.95%
ROIC/WACCN/A
Cap/Depr(3y)21.52%
Cap/Depr(5y)70.21%
Cap/Sales(3y)3%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-137.09%
EPS Next 2Y-90.53%
EPS Next 3Y-72.8%
EPS Next 5YN/A
Revenue 1Y (TTM)122.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.51%
Revenue Next Year-83.22%
Revenue Next 2Y-55.04%
Revenue Next 3Y-37.14%
Revenue Next 5YN/A
EBIT growth 1Y73.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.24%
OCF growth 3YN/A
OCF growth 5YN/A